Edinburgh, UK, 4th January 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control compan
Wed, 04/01/2017 - 07:30
Wed, 04/01/2017 - 07:00
Prokarium and Probiomed today announced the start of their collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability at 40°C for several weeks. The first vaccine to be manufactured will be developed to prevent so-called ‘Montezuma’s revenge’ or diarrhoea, which affects the local population as well travellers in Mexico and many countries.
Thu, 17/11/2016 - 15:00
Saffron Walden, UK, 17th November 2016 / Sciad Newswire / Saffron Walden, UK, 17th November 2016 / Sir Simon Campbell, CBE FRS FMedSci, was welcomed b
Thu, 17/11/2016 - 14:30
London, UK, 17th November 2016 / Sciad Newswire / The pharmaceutical industry is a sector of strategic importance, standing on the threshold of innovation, sa
Mon, 31/10/2016 - 09:00
ReViral, an antiviral drug discovery and development company developing innovative therapies against Respiratory Syncytial Virus (RSV), announced today the initiation of a Phase 1 clinical trial for RV521, its novel orally-active small molecule inhibitor of RSV fusion.
Wed, 26/10/2016 - 17:15
Salt Lake City, USA, 14th October 2016 / Sciad Newswire / The Institute for Healthcare Valuation (IHV) and Consul
Mon, 24/10/2016 - 09:00
NALIA Systems, a developer of novel multiplex immunodiagnostic systems for clinical and research applications, announces the expansion of its board following the recent successful £500,000 fund raising.
Tue, 18/10/2016 - 14:45
London, UK, 18th October 2016 / Sciad Newswire / NALIA Systems, a developer of novel multiplex immunodiagnostic systems for clinical and research applications, ha
Tue, 18/10/2016 - 09:30
An international group of population health experts is calling for sharing of health data to be the norm if precision health agendas are to succeed and build sustainable health systems.
Mon, 17/10/2016 - 01:00
Professor Clifford Hughes was speaking in anticipation of the publication of a White Paper published by the International Journal for Quality in Health Care (ISQua) today which discusses the impact of current and impending pressure of ageing populations which will present significant planning and budgetary challenges for global healthcare systems.